MEDICLIN AG/ DE0006595101 /
| 2024-11-08 7:30:34 PM | Chg. -0.080 | Volume | Bid7:30:37 PM | Ask7:30:37 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.380EUR | -3.25% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 116.85 mill.EUR | - | - |
Assets
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 177.5000 | 194.6000 | 617.5000 | 572 | 508.3000 | ||||||
| Intangible Assets | 6.1000 | 7.8000 | 8.9000 | 8.8000 | 7 | ||||||
| Long-Term Investments | .9000 | .9000 | .9000 | .9000 | .8000 | ||||||
| Fixed Assets | 239.8000 | 296.2000 | 731.8000 | 683.6000 | 615.3000 | ||||||
| Inventories | 7.3000 | 7.5000 | 8.1000 | 9.3000 | 8.5000 | ||||||
| Accounts Receivable | 84 | 93.1000 | 101.1000 | 76.3000 | 81.2000 | ||||||
| Cash and Cash Equivalents | 26.9000 | 33.8000 | 37.2000 | 100.4000 | 119.5000 | ||||||
| Current Assets | 128.9000 | 148.5000 | 166 | 203.9000 | 265.9000 | ||||||
| Total Assets | 368.6000 | 444.7000 | 897.8000 | 887.5000 | 881.2000 | ||||||
Liabilities
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 13.7000 | 17.1000 | 17.6000 | 11.3000 | 13 | ||||||
| Long-term debt | 37.9000 | 85.8000 | 472.2000 | 444.3000 | 397.6000 | ||||||
| Liabilities to Banks | 62.4000 | 120.8000 | 564.8000 | 542.8000 | 514.7000 | ||||||
| Provisions | 86.6000 | 89.5000 | 99.6000 | 107.7000 | 98.6000 | ||||||
| Liabilities | 183.4000 | 253.3000 | 707.1000 | 710.7000 | 698.2000 | ||||||
| Share Capital | 47.5000 | 47.5000 | 47.5000 | 47.5000 | 47.5000 | ||||||
| Total Equity | 185.3000 | 191.4000 | 190.7000 | 176.8000 | 183 | ||||||
| Minority Interests | -.3000 | -.2000 | -.2000 | -.3000 | -.3000 | ||||||
| Total liabilities equity | 368.6000 | 444.7000 | 897.8000 | 887.5000 | 881.2000 | ||||||
Income Statement
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 609.1000 | 645.1000 | 673.1000 | 659.9000 | 673.1000 | ||||||
| Depreciation (total) | 20.4000 | 22.3000 | 71.2000 | 77.3000 | 73.7000 | ||||||
| Operating Result | 6.6000 | 15.1000 | 22.4000 | .2000 | 11.6000 | ||||||
| Interest Income | -2.4000 | -3.3000 | -10.8100 | -10.2500 | -9.2500 | ||||||
| Income Before Taxes | 4.3000 | 11.9000 | 11.6000 | -10.1000 | 2.4000 | ||||||
| Income Taxes | .3000 | 4.1000 | 1.9000 | -1.1000 | 1 | ||||||
| Minority Interests Profit | -.0500 | -.0500 | -.0200 | .0400 | -.0200 | ||||||
| Net Income | 3.9000 | 7.7000 | 9.7000 | -9 | 1.5000 | ||||||
Per Share
Cash Flow
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 19.3000 | 29.7000 | 69.6000 | 118.7000 | 82 | ||||||
| Cash Flow from Investing Activities | -31 | -46.1000 | -35.6000 | -8.6000 | -7.1000 | ||||||
| Cash Flow from Financing | -3.1000 | 23.4000 | -30.5000 | -46.5000 | -55.3000 | ||||||
| Decrease / Increase in Cash | -14.7000 | 6.9000 | 3.4000 | 63.2000 | 19.6000 | ||||||
| Employees | 6,964 | 7,726 | 7,323 | 7,349 | 7,115 | ||||||
